Stiff skin syndrome and myeloma successfully treated with autologous haematopoietic stem cell transplantation (HSCT).

Stiff skin syndrome (SSS) is a rare scleroderma-like syndrome characterised by stone hard skin, joint limitation and progressive restriction of chest that may lead to death. We describe the efficacy of haematopoietic autologous stem cell transplantation (HSCT) in a case of SSS secondary to a smouldering myeloma (SM), with severe joint disability, lung interstitial disease and oesophageal dysfunction. The patient was evaluated at 1, 12 and 18 months after HSCT, clinically (joint motility, HAQ and NYHA for dyspnoea) and instrumentally (DLCO, chest HRCT, oesophagus x-ray). After 18 months since HSCT, we observed a high improvement, contemporaneously to SM remission, of HAQ, joint motility, lung (at DLCO and HRCT) and oesophageal abnormalities.

Citation

Francesca Bandinelli, Riccardo Saccardi, Giuliana Salvadorini, Alberto Bosi, Antonella Gozzini, Marco Matucci Cerinic. Stiff skin syndrome and myeloma successfully treated with autologous haematopoietic stem cell transplantation (HSCT). Clinical and experimental rheumatology. 2013 Mar-Apr;31(2 Suppl 76):181-3

Mesh Tags

PMID: 23910622

search → result